• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝细胞特异性Arid1a缺陷引发小鼠脂肪性肝炎和肝细胞癌。

Hepatocyte-Specific Arid1a Deficiency Initiates Mouse Steatohepatitis and Hepatocellular Carcinoma.

作者信息

Fang Jia-Zhu, Li Chong, Liu Xiao-Yan, Hu Tao-Tao, Fan Zu-Sen, Han Ze-Guang

机构信息

Key Laboratory of Systems Biomedicine (Ministry of Education) and Collaborative Innovation Center of Systems Biomedicine of Rui-Jin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Shanghai-MOST Key Laboratory for Disease and Health Genomics, Chinese National Human Genome Center at Shanghai, Shanghai, China.

出版信息

PLoS One. 2015 Nov 16;10(11):e0143042. doi: 10.1371/journal.pone.0143042. eCollection 2015.

DOI:10.1371/journal.pone.0143042
PMID:26569409
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4646347/
Abstract

ARID1A, encoding a subunit of chromatin remodeling SWI/SNF complexes, has recently been considered as a new type of tumor suppressor gene for its somatic mutations frequently found in various human tumors, including hepatocellular carcinoma (HCC). However, the role and mechanism of inactivated ARID1A mutations in tumorigenesis remain unclear. To investigate the role of ARID1A inactivation in HCC pathogenesis, we generated hepatocyte-specific Arid1a knockout (Arid1aLKO) mice by crossing mice carrying loxP-flanked Arid1a exon 8 alleles (Arid1af/f) with albumin promoter-Cre transgenic mice. Significantly, the hepatocyte-specific Arid1a deficiency results in mouse steatohepatitis and HCC development. In Arid1aLKO mice, we found that innate immune cells, including F4/80+ macrophages and CD11c+ neutrophil cells, infiltrate into the liver parenchyma, accompanied by the increased tumor necrosis factor (TNF)-α and interleukin (IL)-6, and activation of STAT3 and NF-κB pathways. In conclusion, hepatocyte-specific Arid1a deficiency could lead to mouse steatohepatitis and HCC development. This study provides an alternative mechanism by which Arid1a deficiency contributes to HCC tumorigenesis.

摘要

ARID1A编码染色质重塑SWI/SNF复合物的一个亚基,因其体细胞突变在包括肝细胞癌(HCC)在内的各种人类肿瘤中频繁出现,最近被视为一种新型肿瘤抑制基因。然而,ARID1A失活突变在肿瘤发生中的作用和机制仍不清楚。为了研究ARID1A失活在HCC发病机制中的作用,我们通过将携带loxP侧翼的Arid1a外显子8等位基因(Arid1af/f)的小鼠与白蛋白启动子-Cre转基因小鼠杂交,生成了肝细胞特异性Arid1a敲除(Arid1aLKO)小鼠。值得注意的是,肝细胞特异性Arid1a缺陷导致小鼠脂肪性肝炎和HCC发生。在Arid1aLKO小鼠中,我们发现包括F4/80+巨噬细胞和CD11c+中性粒细胞在内的先天免疫细胞浸润到肝实质中,同时肿瘤坏死因子(TNF)-α和白细胞介素(IL)-6增加,STAT3和NF-κB通路激活。总之,肝细胞特异性Arid1a缺陷可导致小鼠脂肪性肝炎和HCC发生。本研究提供了一种Arid1a缺陷促进HCC肿瘤发生的替代机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fc9/4646347/53e53afa830f/pone.0143042.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fc9/4646347/857a3a30c664/pone.0143042.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fc9/4646347/2d0049312578/pone.0143042.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fc9/4646347/88aff1483db9/pone.0143042.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fc9/4646347/ef79c18512a8/pone.0143042.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fc9/4646347/53e53afa830f/pone.0143042.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fc9/4646347/857a3a30c664/pone.0143042.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fc9/4646347/2d0049312578/pone.0143042.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fc9/4646347/88aff1483db9/pone.0143042.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fc9/4646347/ef79c18512a8/pone.0143042.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fc9/4646347/53e53afa830f/pone.0143042.g005.jpg

相似文献

1
Hepatocyte-Specific Arid1a Deficiency Initiates Mouse Steatohepatitis and Hepatocellular Carcinoma.肝细胞特异性Arid1a缺陷引发小鼠脂肪性肝炎和肝细胞癌。
PLoS One. 2015 Nov 16;10(11):e0143042. doi: 10.1371/journal.pone.0143042. eCollection 2015.
2
Arid1a regulates response to anti-angiogenic therapy in advanced hepatocellular carcinoma.Arid1a 调控晚期肝细胞癌对抗血管生成治疗的反应。
J Hepatol. 2018 Mar;68(3):465-475. doi: 10.1016/j.jhep.2017.10.028. Epub 2017 Nov 4.
3
ARID1A represses hepatocellular carcinoma cell proliferation and migration through lncRNA MVIH.ARID1A通过长链非编码RNA MVIH抑制肝癌细胞的增殖和迁移。
Biochem Biophys Res Commun. 2017 Sep 9;491(1):178-182. doi: 10.1016/j.bbrc.2017.07.072. Epub 2017 Jul 14.
4
Toll-like Receptor 4 on Macrophage Promotes the Development of Steatohepatitis-related Hepatocellular Carcinoma in Mice.巨噬细胞上的Toll样受体4促进小鼠脂肪性肝炎相关肝细胞癌的发展。
J Biol Chem. 2016 May 27;291(22):11504-17. doi: 10.1074/jbc.M115.709048. Epub 2016 Mar 28.
5
Promyelocytic leukaemia protein links DNA damage response and repair to hepatitis B virus-related hepatocarcinogenesis.早幼粒细胞白血病蛋白将 DNA 损伤反应和修复与乙型肝炎病毒相关的肝癌发生联系起来。
J Pathol. 2013 Aug;230(4):377-87. doi: 10.1002/path.4195.
6
mTORC1 Promotes ARID1A Degradation and Oncogenic Chromatin Remodeling in Hepatocellular Carcinoma.mTORC1 促进肝癌中 ARID1A 的降解和致癌性染色质重塑。
Cancer Res. 2021 Nov 15;81(22):5652-5665. doi: 10.1158/0008-5472.CAN-21-0206. Epub 2021 Aug 24.
7
Arid1a Has Context-Dependent Oncogenic and Tumor Suppressor Functions in Liver Cancer.Arid1a在肝癌中具有依赖于背景的致癌和肿瘤抑制功能。
Cancer Cell. 2017 Nov 13;32(5):574-589.e6. doi: 10.1016/j.ccell.2017.10.007.
8
The zinc finger protein Miz1 suppresses liver tumorigenesis by restricting hepatocyte-driven macrophage activation and inflammation.锌指蛋白 Miz1 通过限制肝细胞驱动的巨噬细胞活化和炎症来抑制肝肿瘤发生。
Immunity. 2021 Jun 8;54(6):1168-1185.e8. doi: 10.1016/j.immuni.2021.04.027. Epub 2021 May 25.
9
Deletion of HNF1α in hepatocytes results in fatty liver-related hepatocellular carcinoma in mice.肝细胞中HNF1α的缺失会导致小鼠出现与脂肪肝相关的肝细胞癌。
FEBS Lett. 2017 Jul;591(13):1947-1957. doi: 10.1002/1873-3468.12689. Epub 2017 Jun 19.
10
Induction of Steatohepatitis and Liver Tumorigenesis by Enforced Snail Expression in Hepatocytes.肝细胞中强制表达 Snail 诱导肝脂肪变性和肝癌发生。
Am J Pathol. 2020 Jun;190(6):1271-1283. doi: 10.1016/j.ajpath.2020.02.005. Epub 2020 Mar 15.

引用本文的文献

1
Therapeutic targeting of myeloid cells in liver fibrosis: Mechanisms and clinical prospects.肝纤维化中髓系细胞的治疗靶点:机制与临床前景
Animal Model Exp Med. 2025 Jul;8(7):1215-1228. doi: 10.1002/ame2.70053. Epub 2025 Jul 8.
2
Opening and changing: mammalian SWI/SNF complexes in organ development and carcinogenesis.打开和改变:哺乳动物 SWI/SNF 复合物在器官发育和癌症发生中的作用。
Open Biol. 2024 Oct;14(10):240039. doi: 10.1098/rsob.240039. Epub 2024 Oct 30.
3
Epigenetic tuning of tumour-associated macrophages (TAMs): a potential approach in hepatocellular carcinoma (HCC) immunotherapy.

本文引用的文献

1
TERT promoter mutations in primary liver tumors.原发性肝肿瘤中的端粒酶逆转录酶(TERT)启动子突变
Clin Res Hepatol Gastroenterol. 2016 Feb;40(1):9-14. doi: 10.1016/j.clinre.2015.07.006. Epub 2015 Aug 31.
2
Pathway-focused PCR array profiling of enriched populations of laser capture microdissected hippocampal cells after traumatic brain injury.创伤性脑损伤后激光捕获显微切割海马细胞富集群体的通路聚焦PCR阵列分析。
PLoS One. 2015 May 27;10(5):e0127287. doi: 10.1371/journal.pone.0127287. eCollection 2015.
3
Up-Regulation of miR-21 Is Associated with Cervicitis and Human Papillomavirus Infection in Cervical Tissues.
肿瘤相关巨噬细胞(TAMs)的表观遗传调控:肝细胞癌(HCC)免疫治疗的一种潜在方法。
Expert Rev Mol Med. 2024 Sep 25;26:e18. doi: 10.1017/erm.2024.9.
4
The Role of the AT-Rich Interaction Domain 1A Gene () in Human Carcinogenesis.富含AT互作结构域1A基因()在人类致癌过程中的作用 。 (注:这里括号里“()”部分原文缺失具体内容)
Genes (Basel). 2023 Dec 19;15(1):5. doi: 10.3390/genes15010005.
5
SWI/SNF complex, promising target in melanoma therapy: Snapshot view.SWI/SNF复合物,黑色素瘤治疗中有前景的靶点:简要概述。
Front Med (Lausanne). 2023 Feb 9;10:1096615. doi: 10.3389/fmed.2023.1096615. eCollection 2023.
6
Epigenetic modification-related mechanisms of hepatocellular carcinoma resistance to immune checkpoint inhibition.表观遗传学修饰相关机制导致肝癌对免疫检查点抑制的耐药性。
Front Immunol. 2023 Jan 4;13:1043667. doi: 10.3389/fimmu.2022.1043667. eCollection 2022.
7
Arid1a mutation suppresses TGF-β signaling and induces cholangiocarcinoma.Arid1a 突变抑制 TGF-β 信号通路并诱导胆管癌发生。
Cell Rep. 2022 Aug 30;40(9):111253. doi: 10.1016/j.celrep.2022.111253.
8
Effect of CRISPR Knockout of or on Proliferation and Migration of Porcine Hepatocellular Carcinoma.CRISPR敲除或对猪肝细胞癌增殖和迁移的影响。 (注:原文中“Effect of CRISPR Knockout of or on...”这里“of”后面似乎少了具体基因名称等关键信息)
Front Oncol. 2022 May 20;12:904031. doi: 10.3389/fonc.2022.904031. eCollection 2022.
9
ARID1A serves as a receivable biomarker for the resistance to EGFR-TKIs in non-small cell lung cancer.ARID1A 可作为非小细胞肺癌对 EGFR-TKIs 耐药的一个有价值的生物标志物。
Mol Med. 2021 Oct 29;27(1):138. doi: 10.1186/s10020-021-00400-5.
10
The Role of in Tumors: Tumor Initiation or Tumor Suppression?在肿瘤中的作用:肿瘤起始还是肿瘤抑制?
Front Oncol. 2021 Oct 4;11:745187. doi: 10.3389/fonc.2021.745187. eCollection 2021.
miR-21的上调与宫颈组织中的宫颈炎和人乳头瘤病毒感染相关。
PLoS One. 2015 May 26;10(5):e0127109. doi: 10.1371/journal.pone.0127109. eCollection 2015.
4
Decreased expression of ARID1A associates with poor prognosis and promotes metastases of hepatocellular carcinoma.ARID1A表达降低与预后不良相关,并促进肝细胞癌转移。
J Exp Clin Cancer Res. 2015 May 15;34(1):47. doi: 10.1186/s13046-015-0164-3.
5
Coexistent ARID1A-PIK3CA mutations promote ovarian clear-cell tumorigenesis through pro-tumorigenic inflammatory cytokine signalling.ARID1A-PIK3CA共突变通过促肿瘤炎症细胞因子信号传导促进卵巢透明细胞肿瘤发生。
Nat Commun. 2015 Jan 27;6:6118. doi: 10.1038/ncomms7118.
6
Roles of deletion of Arid1a, a tumor suppressor, in mouse ovarian tumorigenesis.Arid1a 缺失在小鼠卵巢肿瘤发生中的作用。
J Natl Cancer Inst. 2014 Jun 4;106(7). doi: 10.1093/jnci/dju146. Print 2014 Jul.
7
Obesity-associated mechanisms of hepatocarcinogenesis.肥胖相关的肝癌发生机制。
Metabolism. 2014 May;63(5):607-17. doi: 10.1016/j.metabol.2014.01.011. Epub 2014 Feb 5.
8
Exome sequencing identifies distinct mutational patterns in liver fluke-related and non-infection-related bile duct cancers.外显子组测序鉴定出肝吸虫相关和非感染相关胆管癌中的不同突变模式。
Nat Genet. 2013 Dec;45(12):1474-8. doi: 10.1038/ng.2806. Epub 2013 Nov 3.
9
Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas.外显子组测序鉴定出肝内胆管癌中 BAP1、ARID1A 和 PBRM1 的频发失活突变。
Nat Genet. 2013 Dec;45(12):1470-1473. doi: 10.1038/ng.2813. Epub 2013 Nov 3.
10
Identification of liver cancer progenitors whose malignant progression depends on autocrine IL-6 signaling.鉴定依赖自分泌 IL-6 信号促进恶性进展的肝癌祖细胞。
Cell. 2013 Oct 10;155(2):384-96. doi: 10.1016/j.cell.2013.09.031.